NEUPRO

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	48

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 10 of 48 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04957420 (ClinicalTrials.gov)	July 1, 2021	27/6/2021	The Practical Effect of Neupro	Neupro's Multicenter and Prospective Observation of Safety and Efficacy in Chinese Mainland Idiopath ...	Parkinson's Disease	Drug: Neupro	Peking University Third Hospital	NULL	Recruiting	18 Years	N/A	All	3000		China
2	EUCTR2021-000867-65-DE (EUCTR)	19/04/2021	16/03/2021	Investigation of the adhesion properties of a newly developed rotigotine-containing patch in patient ...	Comparative, randomized, open, crossover clinical trial to investigate adhesiveness of a newly devel ...	Idiopathic Parkinson's disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Par ...	Product Name: ROT-TDS 8 mg/24 h INN or Proposed INN: ROTIGOTINE Trade Name: Neupro® 8 mg/24 h Product N ...	Luye Pharma Switzerland AG	NULL	Not Recruiting			Female: yes Male: yes	38	Phase 2	Germany
3	NCT04384666 (ClinicalTrials.gov)	June 2, 2020	8/5/2020	A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine Aft ...	A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine Aft ...	Parkinson Disease	Drug: LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection);Other: Neu ...	Luye Pharma Group Ltd.	NULL	Completed	18 Years	45 Years	All	56	Phase 1	United States
4	NCT04183634 (ClinicalTrials.gov)	December 3, 2019	28/11/2019	An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Tra ...	An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Tra ...	Parkinson Disease	Drug: Rotigotine TTS (Test);Drug: Neupro (Reference)	Sandoz	NULL	Terminated	18 Years	80 Years	All	31	Phase 1	Germany
5	NCT03733561 (ClinicalTrials.gov)	November 9, 2018	6/11/2018	A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro	A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine Aft ...	Parkinson Disease	Drug: LY03003;Drug: Neupro 4Mg/24Hr Transdermal Patch	Luye Pharma Group Ltd.	NULL	Completed	18 Years	45 Years	All	40	Phase 1	United States
6	NCT02728947 (ClinicalTrials.gov)	May 2016	31/3/2016	Pharmacokinetic Profile of NeuproPatch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Pati ...	A Single Group and Open-label Study to Evaluate Pharmacokinetic Profile of NeuproPatch Administrated ...	Parkinson's Disease	Drug: ROTIGOTINE	Luye Pharma Group Ltd.	NULL	Completed	18 Years	99 Years	Both	28	Phase 1	United States
7	EUCTR2012-002840-26-RO (EUCTR)	12/11/2013	17/07/2014	Study to test the efficacy of two doses of Rotigotine on depressive mood (apathy) associated with Pa ...	A Multicenter, Multinational, Double-blind, Placebo-controlled, 3-arm Phase 4 Study to Evaluate the ...	Parkinson's disease MedDRA version: 17.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Trade Name: Neupro Product Name: Rotigotine INN or Proposed INN: ROTIGOTINE Trade Name: Neupro Product N ...	UCB Biosciences GmbH	NULL	Not Recruiting			Female: yes Male: yes	504	Phase 4	Serbia;United States;Slovakia;Slovenia;Spain;Ukraine;Turkey;Austria;Italy;Hungary;Poland;Romania;Cro ...
8	NCT02055274 (ClinicalTrials.gov)	October 2013	31/1/2014	Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease	A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's ...	Parkinson's Disease	Drug: LY03003;Drug: Neupro	Luye Pharma Group Ltd.	NULL	Completed	18 Years	N/A	Both	39	Phase 1	United States
9	EUCTR2012-002840-26-BG (EUCTR)	26/04/2013	06/02/2013	Study to test the efficacy of two doses of Rotigotine on depressive mood (apathy) associated with Pa ...	A Multicenter, Multinational, Double-blind, Placebo-controlled, 3-arm Phase 4 Study to Evaluate the ...	Parkinson's disease MedDRA version: 16.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Trade Name: Neupro Product Name: Rotigotine INN or Proposed INN: ROTIGOTINE Trade Name: Neupro Product N ...	UCB Biosciences GmbH	NULL	Not Recruiting			Female: yes Male: yes	504	Phase 4	Serbia;United States;Slovakia;Slovenia;Spain;Ukraine;Turkey;Austria;Italy;Hungary;Poland;Romania;Cro ...
10	EUCTR2012-002608-42-GB (EUCTR)	07/04/2013	01/11/2012	A study to evaluate the efficacy of Rotigotine (the treatment) versus placebo in patients with pain ...	A Multicenter, Multinational, Double-blind, Placebo-controlled, 2-arm Study to Evaluate the Efficacy ...	Parkinson’s disease MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Trade Name: Neupro Product Name: Rotigotine INN or Proposed INN: ROTIGOTINE Trade Name: Neupro Product N ...	UCB Biosciences GmbH	NULL	Not Recruiting			Female: yes Male: yes	478	Phase 4	France;United States;Hungary;Mexico;Slovakia;Argentina;Poland;Ukraine;Russian Federation;Germany;Uni ...

First Previous1 2 3 4 5Next Last